35 related articles for article (PubMed ID: 38621743)
1. M
Di Timoteo G; Giuliani A; Setti A; Biagi MC; Lisi M; Santini T; Grandioso A; Mariani D; Castagnetti F; Perego E; Zappone S; Lattante S; Sabatelli M; Rotili D; Vicidomini G; Bozzoni I
Nat Commun; 2024 Jun; 15(1):5033. PubMed ID: 38866783
[TBL] [Abstract][Full Text] [Related]
2. PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
Tziortzouda P; Steyaert J; Scheveneels W; Sicart A; Stoklund Dittlau K; Barbosa Correia AM; Burg T; Pal A; Hermann A; Van Damme P; Moens TG; Van Den Bosch L
Acta Neuropathol; 2024 Feb; 147(1):41. PubMed ID: 38363426
[TBL] [Abstract][Full Text] [Related]
3. Aberrant protein aggregation in amyotrophic lateral sclerosis.
Wang H; Zeng R
J Neurol; 2024 Jun; ():. PubMed ID: 38869826
[TBL] [Abstract][Full Text] [Related]
4. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
[TBL] [Abstract][Full Text] [Related]
6. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.
Bäumer D; Hilton D; Paine SM; Turner MR; Lowe J; Talbot K; Ansorge O
Neurology; 2010 Aug; 75(7):611-8. PubMed ID: 20668261
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
8. Animal Models of FUS-Proteinopathy: A Systematic Review.
Rezvykh A; Shteinberg D; Bronovitsky E; Ustyugov A; Funikov S
Biochemistry (Mosc); 2024 Jan; 89(Suppl 1):S34-S56. PubMed ID: 38621743
[TBL] [Abstract][Full Text] [Related]
9. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
[TBL] [Abstract][Full Text] [Related]
10. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
11. Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects.
Assoni AF; Foijer F; Zatz M
Stem Cell Rev Rep; 2023 Apr; 19(3):625-638. PubMed ID: 36515764
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]